Case-based learning: understanding and managing levetiracetam-induced psychiatric symptoms
Introduction Levetiracetam is an anticonvulsant that is indicated as monotherapy for partial onset seizures in adults and adolescents aged 16 years and older with newly diagnosed epilepsy1,2. The medicine can also be used as adjunctive therapy for partial onset seizures in patients aged one month and older with epilepsy, in the treatment of myoclonic seizures […]
Publication Details
- Journal
- Pharmaceutical journal/The pharmaceutical journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1211/pj.2025.1.360508
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00